by Robert King | Dec 16, 2019 Major healthcare priorities on drug pricing and ending surprise medical billing appear likely to be punted into 2020. While the House passed a major bill Thursday to give Medicare the power to lower drug prices, the legislation appears highly likely to die in the Senate. A bipartisan House-Senate deal on legislation …